» Articles » PMID: 26183072

Real-time Monitoring of Extracellular Adenosine Using Enzyme-linked Microelectrode Arrays

Overview
Date 2015 Jul 18
PMID 26183072
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Throughout the central nervous system extracellular adenosine serves important neuroprotective and neuromodulatory functions. However, current understanding of the in vivo regulation and effects of adenosine is limited by the spatial and temporal resolution of available measurement techniques. Here, we describe an enzyme-linked microelectrode array (MEA) with high spatial (7500 µm(2)) and temporal (4 Hz) resolution that can selectively measure extracellular adenosine through the use of self-referenced coating scheme that accounts for interfering substances and the enzymatic breakdown products of adenosine. In vitro, the MEAs selectively measured adenosine in a linear fashion (r(2)=0.98±0.01, concentration range=0-15 µM, limit of detection =0.96±0.5 µM). In vivo the limit of detection was 0.04±0.02 µM, which permitted real-time monitoring of the basal extracellular concentration in rat cerebral cortex (4.3±1.5 µM). Local cortical injection of adenosine through a micropipette produced dose-dependent transient increases in the measured extracellular concentration (200 nL: 6.8±1.8 µM; 400 nL: 19.4±5.3 µM) [P<0.001]. Lastly, local injection of dipyridamole, which inhibits transport of adenosine through equilibrative nucleoside transporter, raised the measured extracellular concentration of adenosine by 120% (5.6→12.3 µM) [P<0.001]. These studies demonstrate that MEAs can selectively measure adenosine on temporal and spatial scales relevant to adenosine signaling and regulation in normal and pathologic states.

Citing Articles

Effect of adenosinergic manipulations on amygdala-kindled seizures in mice: Implications for sudden unexpected death in epilepsy.

Purnell B, Petrucci A, Li R, Buchanan G Epilepsia. 2024; 65(9):2812-2826.

PMID: 38980980 PMC: 11534534. DOI: 10.1111/epi.18059.


Spreading depolarizations pose critical energy challenges in acute brain injury.

Lindquist B J Neurochem. 2023; 168(5):868-887.

PMID: 37787065 PMC: 10987398. DOI: 10.1111/jnc.15966.


The adenosine hypothesis of schizophrenia into its third decade: From neurochemical imbalance to early life etiological risks.

Singer P, Yee B Front Cell Neurosci. 2023; 17:1120532.

PMID: 36998267 PMC: 10043328. DOI: 10.3389/fncel.2023.1120532.


Micro/Nano Electrode Array Sensors: Advances in Fabrication and Emerging Applications in Bioanalysis.

Liu Y, Li X, Chen J, Yuan C Front Chem. 2020; 8:573865.

PMID: 33324609 PMC: 7726471. DOI: 10.3389/fchem.2020.573865.


Imaging Guidance for Therapeutic Delivery: The Dawn of Neuroenergetics.

Alambyan V, Pace J, Sukpornchairak P, Yu X, Alnimir H, Tatton R Neurotherapeutics. 2020; 17(2):522-538.

PMID: 32240530 PMC: 7283376. DOI: 10.1007/s13311-020-00843-4.


References
1.
Dale N, Pearson T, Frenguelli B . Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J Physiol. 2000; 526 Pt 1:143-55. PMC: 2269993. DOI: 10.1111/j.1469-7793.2000.00143.x. View

2.
Lindquist B, Shuttleworth C . Spreading depolarization-induced adenosine accumulation reflects metabolic status in vitro and in vivo. J Cereb Blood Flow Metab. 2014; 34(11):1779-90. PMC: 4269755. DOI: 10.1038/jcbfm.2014.146. View

3.
Thomas T, Grandy D, Gerhardt G, Glaser P . Decreased dopamine D4 receptor expression increases extracellular glutamate and alters its regulation in mouse striatum. Neuropsychopharmacology. 2008; 34(2):436-45. PMC: 7223095. DOI: 10.1038/npp.2008.74. View

4.
Chen F, Qi Z, Luo Y, Hinchliffe T, Ding G, Xia Y . Non-pharmaceutical therapies for stroke: mechanisms and clinical implications. Prog Neurobiol. 2014; 115:246-69. PMC: 3969942. DOI: 10.1016/j.pneurobio.2013.12.007. View

5.
Barbosa R, Lourenco C, Santos R, Pomerleau F, Huettl P, Gerhardt G . In vivo real-time measurement of nitric oxide in anesthetized rat brain. Methods Enzymol. 2008; 441:351-67. DOI: 10.1016/S0076-6879(08)01220-2. View